2025 ISPE Pharma 4.0™ Conference

The 2025 ISPE Pharma 4.0™ Conference will bring together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists, and international regulators to network, share insights, and provide an outlook on digital transformation, automation, and the evolving landscape and future of Pharma 4.0™. Pharma 4.0 is a holistic end-to-end implementation of digitalization across all stages of project execution, manufacturing, and regulatory processes and along the pharmaceutical supply chain. The key challenges of drug shortages and drug availability can be tackled by the increasing support and impact of innovative enabling technologies, such as artificial intelligence (AI), machine learning (ML), virtual and augmented reality, IIoT, Gxp Cloud & low code platforms, robotics, advanced modeling and automation. Digital transformation is significantly advancing pharmaceutical quality as it builds the foundation for the Quality by Design and process understanding approach to manage the holistic control strategy concept based on an accurate data management and well understood and controlled process models.

More than ever, an emphasis on cross-discipline collaboration is needed to holistically implement and integrate these groundbreaking technologies, while ensuring operational excellence, organizational readiness, and preparing the workforce of the future. This conference seeks to illuminate their profound impact on efficiency, innovation, and operational excellence and even more: its transformational capabilities.

The conference will provide a leading interdisciplinary platform for all stakeholders of the pharmaceutical chain. These sessions showcase recent innovations and trends and directly discuss practical challenges and solutions from a technical, logistical, and regulatory perspective. Our education program offers cutting-edge technical sessions shedding light on the latest advancements in areas like supply chain operations, facilities design and maintenance, and regulatory affairs, with a focus on how Pharma 4.0 is driving the next generation of product development, production systems, and quality assurance.

Participants will have the opportunity to engage with industry leaders, regulators, and peers through networking events and the conference program.